Bioventures Opportunities G. Yk Sells 1,343,801 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Bioventures Opportunities G. Yk sold 1,343,801 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $0.08, for a total value of $107,504.08. Following the transaction, the insider now directly owns 17,618,618 shares in the company, valued at approximately $1,409,489.44. This represents a 7.09 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

CERo Therapeutics Price Performance

Shares of CERO stock opened at $0.06 on Friday. The stock has a 50 day moving average price of $0.13 and a 200 day moving average price of $0.21. CERo Therapeutics Holdings, Inc. has a 52-week low of $0.06 and a 52-week high of $12.80.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.